Guo-Ping Chang-Chien Selected Research

Guo-Ping Chang-Chien Research Topics

Disease

23	Hypertension (High Blood Pressure) 01/2024 - 01/2019
15	Chronic Renal Insufficiency 12/2023 - 11/2018
14	AIDS-Related Complex (ARC) 01/2014 - 10/2004
3	Neoplasms (Cancer) 07/2023 - 07/2007
3	Kidney Diseases (Kidney Disease) 07/2021 - 09/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 10/2012
2	Body Weight (Weight, Body) 02/2022 - 01/2022
2	Hypertrophy 07/2021 - 09/2020
2	Inflammation (Inflammations) 05/2018 - 10/2012
1	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2024
1	Heart Failure 01/2024
1	Retinal Degeneration 01/2022
1	Retinal Diseases 01/2022
1	Macular Degeneration (Age-Related Maculopathy) 01/2022
1	Renal Hypertension 07/2021
1	Uremia 09/2020
1	Dysbiosis 09/2020
1	Fetal Weight 09/2020
1	Arthritis (Polyarthritis) 05/2018
1	Asthma (Bronchial Asthma) 05/2018
1	Hypersensitivity (Allergy) 05/2018
1	Osteoporosis 07/2013
1	Hepatocellular Carcinoma (Hepatoma) 06/2009

Drug/Important Bio-Agent (IBA)

14	Polychlorinated Dibenzodioxins (TCDD)IBA 08/2021 - 10/2004
8	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2024 - 09/2020
8	trimethyloxamine (trimethylamine N-oxide)IBA 01/2023 - 11/2018
7	Adenine FDA LinkGeneric 01/2024 - 09/2020
5	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 06/2023 - 09/2020
5	AluminumIBA 01/2008 - 10/2004
4	AntioxidantsIBA 01/2024 - 09/2020
4	ResveratrolIBA 01/2023 - 12/2020
4	trimethylamineIBA 08/2021 - 01/2019
4	Solid WasteIBA 01/2011 - 10/2004
3	Tryptophan (L-Tryptophan)FDA Link 04/2024 - 02/2022
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2023
3	FructoseIBA 03/2023 - 01/2019
3	Butyrates (Butyrate)IBA 03/2023 - 01/2023
3	DioxinsIBA 07/2020 - 07/2007
3	DibenzofuransIBA 11/2016 - 02/2005
3	GasesIBA 01/2011 - 02/2005
3	Polychlorinated DibenzofuransIBA 06/2010 - 02/2005
2	MelatoninIBA 04/2024 - 07/2021
2	Antihypertensive Agents (Antihypertensives)IBA 01/2024 - 02/2023
2	sodium thiosulfate FDA Link 06/2023 - 01/2022
2	PropionatesIBA 03/2023 - 08/2022
2	allyl sulfideIBA 11/2022 - 01/2021
2	Acetates (Acetic Acid Esters)FDA Link 07/2022 - 01/2019
2	Volatile Fatty AcidsIBA 08/2021 - 01/2019
2	3,3-dimethylbutan-1-olIBA 08/2021 - 01/2019
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 07/2021 - 01/2021
2	Coal AshIBA 05/2008 - 09/2007
2	Medical Waste (Waste, Medical)IBA 07/2007 - 10/2004
1	5-Hydroxytryptophan (5 Hydroxytryptophan)IBA 04/2024
1	Serotonin (5 Hydroxytryptamine)IBA 04/2024
1	CitrullineIBA 01/2024
1	GraphiteIBA 01/2024
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2024
1	Platelet Factor 4IBA 12/2023
1	Taurine FDA Link 11/2023
1	Tyrosine (L-Tyrosine)FDA Link 07/2023
1	SulfurIBA 06/2023
1	AngiotensinsIBA 02/2023
1	ReninIBA 02/2023
1	2,2'- (hydroxynitrosohydrazono)bis- ethanamineIBA 02/2023
1	Diethylhexyl Phthalate (DEHP)IBA 01/2023
1	phthalic acid (phthalate)IBA 01/2023
1	EstersIBA 01/2023
1	PolyphenolsIBA 01/2023
1	Prorenin ReceptorIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Type 1 Angiotensin ReceptorIBA 01/2023
1	Butyric Acid (Butanoic Acid)IBA 10/2022
1	Minocycline (Cyclops)FDA LinkGeneric 07/2022
1	indoleIBA 02/2022
1	Cysteine (L-Cysteine)FDA Link 02/2022
1	Drinking WaterIBA 01/2022
1	sodium iodateIBA 01/2022
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 08/2021
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 08/2021
1	Uremic ToxinsIBA 07/2021
1	PhytochemicalsIBA 01/2021
1	PrebioticsIBA 12/2020
1	Acetylcysteine (Siran)FDA LinkGeneric 09/2020
1	dimethylamine (dimethylamine nitrate)IBA 01/2020
1	GlucocorticoidsIBA 05/2018
1	Triamcinolone (Aristocort)FDA Link 05/2018
1	Syntex adjuvant formulationIBA 01/2014
1	Selective Estrogen Receptor Modulators (SERM)IBA 07/2013
1	Raloxifene Hydrochloride (Evista)FDA Link 07/2013
1	Particulate MatterIBA 10/2012
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 10/2012
1	pentabromodiphenyl ether (PBDE)IBA 10/2010
1	MetalsIBA 06/2009
1	LuciferasesIBA 06/2009

Therapy/Procedure

9	Therapeutics 08/2022 - 07/2020
1	Quantum Dots (Quantum Dot) 01/2024
1	Oral Administration 01/2022